Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12871626 | 0.85 | CYP2C9 (0.41) | CYP2C9GFERGAANR3C1LMNA | |
| SCHEMBL971293 | 0.82 | CYP2C9 (0.40) | CYP2C9GFERGAANR3C1LMNA | |
| SCHEMBL28139455 | 0.80 | CYP2C9 (0.39) | CYP2C9GFERGAA | |
| SCHEMBL31206423 | 0.76 | GAA (0.37) | GAA | |
| SCHEMBL19615346 | 0.76 | GAA (0.37) | GAA | |
| SCHEMBL13184316 | 0.75 | KDM4E (0.46) | GAALMNARAB9A | |
| SCHEMBL32686853 | 0.73 | ADCY10 (0.30) | — | |
| SCHEMBL32686744 | 0.73 | ADCY10 (0.30) | — | |
| SCHEMBL12871802 | 0.72 | GAA (0.45) | CYP2C9GFERGAANR3C1LMNA | |
| SCHEMBL7838461 | 0.71 | GAA (0.59) | CYP2C9GFERGAANR3C1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102007103-A | Substituted sulfonic acid amide compounds | BASF SE | 2011-04-06 | — | — | CN | disclosed |
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | BASF SE (DE) | 2011-01-20 | — | — | US | disclosed |
| EP-2252590-A1 | SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS | BASF SE (DE) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009101082-A1 | SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS | BASF SE (DE) | 2009-08-20 | — | — | WO | disclosed |
| CN-101362720-A | Pyrazole methanol esters compounds, preparation method and application thereof | JIANGSU PESTICIDE RES INST CO (CN) | 2009-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | STS, NAPA, NAAA | CYP2C9 647/4885GFER 59/4885GAA 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.